Product Code: ETC8851054 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The sartans market in the Philippines is expanding due to the high prevalence of hypertension and cardiovascular diseases. Sartans, which are angiotensin II receptor blockers (ARBs), are widely prescribed to manage blood pressure and heart-related conditions. Market growth is driven by increased health awareness and generic drug availability. However, regulatory challenges and competition from alternative treatments may affect expansion.
The rising prevalence of hypertension and cardiovascular diseases in the Philippines is a significant driver of the sartans market. Sartans, a class of angiotensin receptor blockers (ARBs), are widely used to manage high blood pressure and heart failure. Growing awareness of cardiovascular health, increased healthcare spending, and government initiatives promoting preventive care are supporting market growth.
The sartans market is affected by stringent regulatory scrutiny due to concerns over impurities in certain formulations. Price fluctuations and supply chain disruptions impact the availability of these drugs. Additionally, competition from newer classes of antihypertensive drugs affects market growth.
The growing burden of hypertension and cardiovascular diseases in the Philippines is fueling demand for Sartans, a class of angiotensin receptor blockers (ARBs) used for blood pressure management. Investment opportunities include setting up local pharmaceutical manufacturing, enhancing supply chain capabilities for generic Sartans, and collaborating with healthcare professionals to promote patient education and adherence programs. The rising adoption of combination therapies also presents strong market potential.
The DOH and FDA oversee the regulation of sartans, ensuring they meet safety and efficacy standards. Government initiatives support affordable access to hypertension medications. Policies promote research on improving sartan-based treatments.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Sartans Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Sartans Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Sartans Market - Industry Life Cycle |
3.4 Philippines Sartans Market - Porter's Five Forces |
3.5 Philippines Sartans Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Philippines Sartans Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Philippines Sartans Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Philippines Sartans Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Sartans Market Trends |
6 Philippines Sartans Market, By Types |
6.1 Philippines Sartans Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Sartans Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Philippines Sartans Market Revenues & Volume, By Valsartan, 2021- 2031F |
6.1.4 Philippines Sartans Market Revenues & Volume, By Telmisartan, 2021- 2031F |
6.1.5 Philippines Sartans Market Revenues & Volume, By Losartan, 2021- 2031F |
6.1.6 Philippines Sartans Market Revenues & Volume, By Irbesartan, 2021- 2031F |
6.1.7 Philippines Sartans Market Revenues & Volume, By Azilsartan, 2021- 2031F |
6.1.8 Philippines Sartans Market Revenues & Volume, By Olmesartan, 2021- 2031F |
6.2 Philippines Sartans Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Philippines Sartans Market Revenues & Volume, By Valsartan, 2021- 2031F |
6.2.3 Philippines Sartans Market Revenues & Volume, By Telmisartan, 2021- 2031F |
6.2.4 Philippines Sartans Market Revenues & Volume, By Losartan, 2021- 2031F |
6.2.5 Philippines Sartans Market Revenues & Volume, By Irbesartan, 2021- 2031F |
6.2.6 Philippines Sartans Market Revenues & Volume, By Azilsartan, 2021- 2031F |
6.2.7 Philippines Sartans Market Revenues & Volume, By Olmesartan, 2021- 2031F |
6.3 Philippines Sartans Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Philippines Sartans Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Philippines Sartans Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.3.4 Philippines Sartans Market Revenues & Volume, By Others, 2021- 2031F |
7 Philippines Sartans Market Import-Export Trade Statistics |
7.1 Philippines Sartans Market Export to Major Countries |
7.2 Philippines Sartans Market Imports from Major Countries |
8 Philippines Sartans Market Key Performance Indicators |
9 Philippines Sartans Market - Opportunity Assessment |
9.1 Philippines Sartans Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Philippines Sartans Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Philippines Sartans Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Philippines Sartans Market - Competitive Landscape |
10.1 Philippines Sartans Market Revenue Share, By Companies, 2024 |
10.2 Philippines Sartans Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |